BioCentury
ARTICLE | Company News

Sonus, Synt:em deal

March 21, 2005 8:00 AM UTC

Sonus Pharmaceuticals Inc. (SNUS), Bothell, Wash. Synt:em S.A., Nimes, France Business: Drug delivery, Neurology, Cancer SNUS terminated its proposed stock acquisition of Synt:em in order to focus on...